FranciscoAKerdelMD

Dermatology • Coconut Grove, FL

Physician

Join to view full profile

Dr. Kerdel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Kerdel's full profile

Already have an account?

Office
836 Ponce de Leon Blvd
Ste 204
Coconut Grove, FL 33134
Phone+1 305-324-2110

Fax+1 305-325-0919
Is this information wrong?

Education & Training

Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1981 - 1984
Guy's, King's and St Thomas' School of Medical EducationClass of 1979

Certifications & Licensure

FL State Medical License 1987 - 2026
American Board of Dermatology Dermatology
American Board of Dermatology Dermatological Immunology/Diagnostic & Laboratory Immunology

Awards, Honors, & Recognition

Top Doctors:South Florida Castle Connolly, 2012
Top Doctors: Florida Castle Connolly, 2000
Fellow (FAAD) American Academy of Dermatology
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Use of KC706 for the Treatment of Pemphigus Vulgaris Start of enrollment: 2007 Nov 01
Completed
Phase 2
Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa Start of enrollment: 2005 Jun 01
Completed
Phase 2
The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus Start of enrollment: 2008 Oct 01
Unknown status
Phase 2
To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa Start of enrollment: 2007 Feb 01
Completed
Phase 2
Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell Lymphoma Start of enrollment: 2010 May 01
Unknown status
Phase 2
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO) Start of enrollment: 2014 Jun 16
Completed
Phase 3
A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Nitrofurantoin-induced splinter hemorrhages: A forgotten culprit.
Ana Sofia Acosta, Krystina Khalil, Zainab Jafri, Francisco Kerdel> ;JAAD Case Reports. 2024 May 1
Recurrent giant cellulitis-like Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine.
Penelope Hirt, Lily Park, Carly E Wallace, Francisco Kerdel> ;Dermatology Reports. 2023 Sep 12
Pityriasis Lichenoides-Like Mycosis Fungoides: A Case Report.
Lily Park, Claudia Green, Derrek M Giansiracusa, Penelope Hirt, Carlos Ricotti, Francisco Kerdel> ;Cureus. 2023 Mar 1
2 citations
Improvement of refractory pyoderma gangrenosum with adjunctive maggot debridement therapy.
Lauren Dozier, Marissa Ceresnie, Jacquiline Habashy, Francisco Kerdel> ;International Journal of Dermatology. 2023 Aug 1
3 citations
A case of erythrodermic mycosis fungoides responding to upadacitinib.
David E Castillo, Paolo Romanelli, Hadar Lev-Tov, Francisco Kerdel> ;JAAD Case Reports. 2022 Dec 1
8 citations
Three-year U.S. pharmacovigilance report of brodalumab.
Mark Lebwohl, Craig L. Leonardi, April W. Armstrong, Nicole Rawnsley, Binu Alexander, Earl Goehring, Francisco A. Kerdel, Abby Jacobson> ;Dermatologic Therapy. 2021 Aug 21
4 citations
Lichenoid drug eruption after treatment with ixekizumab for plaque psoriasis.
Neda Ghiam, Oben Ojong, Gabriella Vasile, Paolo Romanelli, Francisco A. Kerdel> ;Dermatology Online Journal. 2020 Dec 15
1 citations
Erosive pustular dermatosis after CO2 laser resurfacing in mother and daughter.
Natalie M. Williams, Michael Abrouk, Francisco A. Kerdel, Robert S. Kirsner> ;Dermatologic Therapy. 2020 Nov 1
42 citations
A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain
Alice B. Gottlieb, Nicola E. Natsis, Francisco A. Kerdel, Seth B Forman, Edgar Gonzalez, Gilberto Jimenez, Liliam Hernandez, Jessica A. Kaffenberger, Giancarlo Guido, ...> ;The Journal of Investigative Dermatology. 2020 Aug 1
9 citations
Emerging drugs for the treatment of hidradenitis suppurativa
Alecia S Folkes, Faris Z Hawatmeh, Alan Wong, Francisco A Kerdel> ;Expert Opinion on Emerging Drugs. 2020 Jul 22
8 citations
“Apremilast and Psoriasis in the Real World: A Retrospective Case Series”
Lauren Dozier, Gregory Bartos, Francisco A. Kerdel> ;Journal of the American Academy of Dermatology. 2020 Jul 1
14 citations
Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice.
Errol P. Prens, Aida Lugo-Somolinos, Amy S. Paller, Francisco A. Kerdel, Yinghui Duan, Henrique D. Teixeira, Michelle Longcore, Alexa B. Kimball> ;American Journal of Clinical Dermatology. 2020 Feb 19
3 citations
Consistent response to guselkumab treatment between Hispanic and non-Hispanic patients with psoriasis: an analysis from VOYAGE 1 and VOYAGE 2.
Luis Puig, Jashin J. Wu, Melinda Gooderham, Yin You, Yaung-Kaung Shen, Bruce Randazzo, Francisco A. Kerdel> ;The Journal of Dermatological Treatment. 2021 Jul 4
5 citations
A phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a halobetasol propionate 0.01% lotion and hal...
Francisco A. Kerdel, Zoe Diana Draelos, Stephen K. Tyring, Tina Lin, Radhakrishnan Pillai> ;The Journal of Dermatological Treatment. 2019 May 19
4 citations
Multiple Facial Lesions of Recalcitrant Pyoderma Gangrenosum Successfully Treated with Adalimumab.
Raymond E. Kleinfelder, Nady Hin, Stefanie Cubelli, Allan Snyder, Francisco Kerdel, Brad P. Glick> ;The Journal of Clinical and Aesthetic Dermatology. 2019 May 1
20 citations
Apremilast for the Treatment of Mild-to-Moderate Hidradenitis Suppurativa in a Prospective, Open-Label, Phase 2 Study
Franz R. Kerdel, Fabio A. Azevedo, Christina Kerdel Don, Frank A. Don, Gabriella Fabbrocini, Francisco A. Kerdel> ;Journal of Drugs in Dermatology. 2019 Feb 1
1 citations
Safety and Efficacy of a Once-Daily Halobetasol Propionate 0.01% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of Two Phase 3 Randomized Cont...
Lawrence Green, Francisco A. Kerdel, Fran E Cook-Bolden, Jerry Bagel, Tina Lin, Gina Martin, Radhakrishnan Pillai, Robert Israel, Tage Ramakrishna> ;Journal of Drugs in Dermatology. 2018 Oct 1
12 citations
The Importance of Early Treatment in Psoriasis and Management of Disease Progression.
Francisco A. Kerdel, Frank A. Don> ;Journal of Drugs in Dermatology. 2018 Jul 1
16 citations
Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis.
Robert Bissonnette, Francisco A. Kerdel, Luigi Naldi, Kim A. Papp, Claudia Galindo, Wayne Langholff, Kezhen L. Tang, Philippe Szapary, Steven Fakharzadeh, Bhaskar Sriv...> ;Journal of Drugs in Dermatology. 2017 Oct 1
19 citations
Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis.
Robert Bissonnette, Francisco A. Kerdel, Luigi Naldi, Kim A. Papp, Claudia Galindo, Wayne Langholff, Kezhen L. Tang, Philippe Szapary, Steven Fakharzadeh, Bhaskar Sriv...> ;Journal of Drugs in Dermatology. 2017 Oct 1
31 citations
Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry.
Alan Menter, Diamant Thaçi, Jashin J. Wu, William Abramovits, Francisco A. Kerdel, Dilek Arikan, Dianlin Guo, Arijit Ganguli, Mareike Bereswill, Anne Camez, Wendell C....> ;Dermatology and Therapy. 2017 Aug 16
33 citations
Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3)
Kristian Reich, Craig L. Leonardi, Mark Lebwohl, Francisco A. Kerdel, Yukari Okubo, Ricardo Romiti, Orin Goldblum, Ellen B. Dennehy, Lisa Kerr, Howard Sofen> ;The Journal of Dermatological Treatment. 2017 May 19
1 citations
Carcinoma erysipeloides due to primary cutaneous squamous cell carcinoma.
Suchismita Paul, Elizabeth Yim, Xiaolong Zhou, Erin X. Wei, Jeong Hee Cho-Vega, Clara Milikowski, Francisco A. Kerdel> ;Indian Journal of Dermatology, Venereology and Leprology. 2017 May 1
2 citations
Update on TNF Inhibitors.
Francisco A Kerdel> ;Seminars in Cutaneous Medicine and Surgery. 2016 Jun 1
175 citations
Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
Alan Menter, Kim A. Papp, Melinda Gooderham, David M. Pariser, Matthias Augustin, Francisco A. Kerdel, Steven Fakharzadeh, Kavitha Goyal, S. Calabro, Wayne Langholff, ...> ;Journal of the European Academy of Dermatology and Venereology. 2016 Jul 1
Join now to see all

Lectures

Biologic Therapy in Dermatology Beyond Psoriasis
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/4/2019
13th Las Vegas Dermatology Seminar
Global Academy for Medical Education (Elsevier), Las Vegas, Nevada - 11/1/2012

Press Mentions

Ortho Dermatologics’ Bryhali Lotions Performs Well in Two Phase 3 Psoriasis TrialsOctober 2nd, 2018
Biologics Offer Promise for Hidradenitis Suppurativa TreatmentFebruary 19th, 2018
XBiotech Announces First Patient in Phase 2 Study Evaluating MABp1 in Patients with Atopic DermatitisMay 23rd, 2018